Terug
Dagbereik
€ 30,00
€ 30,00
52-Weeksbereik
€ 24,00
€ 32,28
Volume
200
50D / 200D Gem.
€ 30,00
/
€ 28,02
Vorige Slotkoers
€ 30,00
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 46,0 | 0,4 |
| P/B | 1,4 | 2,9 |
| ROE % | 2,9 | 3,7 |
| Net Margin % | 2,3 | 3,9 |
| Rev Growth 5Y % | -1,3 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 2,46
€ 2,46 – € 2,46
|
630 M | 1 |
| FY2026 |
€ 2,38
€ 2,38 – € 2,38
|
600 M | 1 |
Belangrijkste Punten
Revenue declined -1,29% annually over 5 years
Earnings declined -68,36% over the past year
ROE of 2,94% is below average
Debt/Equity of 0,04 — conservative balance sheet
Generating 23,60M in free cash flow
P/E of 45,95 — premium valuation
Groei
Revenue Growth (5Y)
-1,29%
Revenue (1Y)-1,15%
Earnings (1Y)-68,36%
FCF Growth (3Y)-23,28%
Kwaliteit
Return on Equity
2,94%
ROIC3,00%
Net Margin2,33%
Op. Margin3,23%
Veiligheid
Debt / Equity
0,04
Current Ratio2,51
Interest Coverage12,91
Waardering
P/E Ratio
45,95
P/B Ratio1,38
EV/EBITDA29,94
Dividend Yield0,05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1,15% | Revenue Growth (3Y) | -4,47% |
| Earnings Growth (1Y) | -68,36% | Earnings Growth (3Y) | -49,63% |
| Revenue Growth (5Y) | -1,29% | Earnings Growth (5Y) | -18,90% |
| Profitability | |||
| Revenue (TTM) | 487,56M | Net Income (TTM) | 11,34M |
| ROE | 2,94% | ROA | 1,97% |
| Gross Margin | 73,58% | Operating Margin | 3,23% |
| Net Margin | 2,33% | Free Cash Flow (TTM) | 23,60M |
| ROIC | 3,00% | FCF Growth (3Y) | -23,28% |
| Safety | |||
| Debt / Equity | 0,04 | Current Ratio | 2,51 |
| Interest Coverage | 12,91 | Dividend Yield | 0,05% |
| Valuation | |||
| P/E Ratio | 45,95 | P/B Ratio | 1,38 |
| P/S Ratio | 1,07 | PEG Ratio | -0,62 |
| EV/EBITDA | 29,94 | Dividend Yield | 0,05% |
| Market Cap | 520,87M | Enterprise Value | 471,13M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 487,56M | 493,25M | 534,24M | 455,20M | 513,58M |
| Net Income | 11,34M | 35,83M | 44,67M | 28,56M | 26,21M |
| EPS (Diluted) | 0,65 | 2,06 | 2,57 | 1,63 | 1,50 |
| Gross Profit | 358,76M | 358,08M | 379,73M | 327,62M | 394,74M |
| Operating Income | 15,74M | 42,29M | 63,45M | 46,84M | 38,19M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 576,33M | 590,20M | 789,49M | 770,70M | 781,82M |
| Total Liabilities | 198,15M | 198,70M | 232,15M | 238,93M | 272,65M |
| Shareholders' Equity | 378,15M | 393,66M | 557,62M | 531,74M | 509,14M |
| Total Debt | 14,97M | 13,70M | 22,17M | 12,61M | 12,43M |
| Cash & Equivalents | 64,71M | 74,04M | 250,95M | 234,50M | 234,69M |
| Current Assets | 280,99M | 286,21M | 477,83M | 452,36M | 441,46M |
| Current Liabilities | 111,82M | 126,33M | 153,19M | 158,24M | 176,55M |